Rapid Research in Diagnostics Development for TB Network
Studying Tuberculosis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Adithya Cattamanchi, MDUniversity of California, San Francisco
- Intervention
- Novel mycobacterial culture techniques(diagnostic_test)
- Enrollment
- 26436 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2021 – 2031
Study locations (16)
- National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia
- Chitoor (Christian Medical College satellite campus), Vellore, India
- Christian Medical College CMC Pulmonary Outpatient Department, Vellore, India
- Primary care clinics (Shalom/LCC, CHAD), Vellore, India
- Zankli Research Center, Abuja, Nigeria
- De La Salle Medical and Health Sciences Institute, Dasmariñas, Philippines
- Brooklyn Chest Hospital, Cape Town, South Africa
- Khayelitsha District Health Center, Cape Town, South Africa
- Kraaifontein Community Health Clinic, Cape Town, South Africa
- Scottsdene primary care clinic, Cape Town, South Africa
- Wallacedene primary care clinic, Cape Town, South Africa
- Kisenyi Health Center, Kampala, Uganda
- Mulago Outpatient Department, Kampala, Uganda
- Hanoi Lung Hospital, Outpatient departments, Hanoi, Vietnam
- National Lung Hospital, Outpatient departments, Hanoi, Vietnam
- +1 more locations on ClinicalTrials.gov
Collaborators
University Hospital Heidelberg · Christian Medical College, Vellore, India · Vietnam National Lung Hospital · De La Salle University Medical Center · University of Stellenbosch · Makerere University · Johns Hopkins Bloomberg School of Public Health · Harvard Medical School (HMS and HSDM) · Stanford University · Foundation for Innovative New Diagnostics, Switzerland · Socios En Salud Sucursal, Peru · Federal University of Mato Grosso · Medical Research Council · National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia · Centre for Infectious Disease Research in Zambia · National Institute of Allergy and Infectious Diseases (NIAID) · Zankli Research Center · University of California, Irvine · Johns Hopkins University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04923958 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine